Kusajili – Clinical trials directory

Result of your search per sponsor: Bifodan A/S (Denmark)

Woman Max 99 years
Bifodan A/S (Denmark) Update Il y a 4 ans

A prospective, placebo-controlled, double-blind study for the investigation of the effect and safety of EcoVag® as adjuvant treatment after treatment with clindamycin against bacterial vaginosis Not provided at time of registration

Country Norway
organs None
Specialty None

Closed trial

More information